ChromaDex (CDXC) Tops Q3 EPS by 1c

ChromaDex (NASDAQ: CDXC) reported Q3 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $25.6 million versus the consensus estimate of $24.03 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.

You May Also Be Interested In

• Berkshire shares climb to highest level under Abel on strong results, new stakes
• Jade Biosciences (JBIO) PT Raised to $47 at Wedbush
• Benchmark Reiterates Buy Rating on Take-Two Interactive (TTWO)